Candel Therapeutics, Inc. — SlamSEC

Candel Therapeutics, Inc.

Nasdaq:CADL

Biological Products, (No Diagnostic Substances)·NEEDHAM, MA

Governanceproxy statements · beneficial ownership

Proxy Statements

6 shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
5/30/24	DEF 14A	DEF 14A	→
5/23/23	DEF 14A	DEF 14A	→
9/2/22	DEFA14A	DEFA14A	→
9/2/22	DEF 14A	DEF 14A	→

Ownership Filings

40 shown

Filed	Form	Description
2/26/26	4	4	→
1/28/26	4	4	→
1/28/26	4	4	→
1/28/26	4	4	→
1/28/26	4	4	→
1/28/26	4	4	→
↓